Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc-Reference-Cited by-同舟云学术

Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc

Published:2011-10-01 Issue:7 Volume:53 Page:732-742
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Swenson Luke C.,Mo Theresa,Dong Winnie W. Y.,Zhong Xiaoyin,Woods Conan K.,Thielen Alexander,Jensen Mark A.,Knapp David J. H. F.,Chapman Douglass,Portsmouth Simon,Lewis Marilyn,James Ian,Heera Jayvant,Valdez Hernan,Harrigan P. Richard

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/53/7/732/11061520/cir493.pdf

Reference29 articles.

1. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5;Nature,1996

2. Changing virus-host interactions in the course of HIV-1 infection;Immunol Rev,1994

3. Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy;AIDS,2004

4. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals;J Infect Dis,2005

5. Maraviroc (UK-427, 857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity;Antimicrob Agents Chemother,2005

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Genotypic Assay to Quantify CXCR4- and CCR5-Tropic Human Immunodeficiency Virus Type-1 (HIV-1) Populations and a Comparison to Trofile®;Viruses;2024-03-27

2. Molecular testing for human immunodeficiency virus;Diagnostic Molecular Pathology;2024

3. Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants;Frontiers in Virology;2023-11-16

4. HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment;Journal of Antimicrobial Chemotherapy;2022-11-30

5. Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease;Journal of Antimicrobial Chemotherapy;2021-09-16